CNPT-101101

N/A

Report date: 2024/01/03 14:23:57
NME

Base Information

Drug NameCNPT-101101
Drug Alias NameCNPT-101101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFronthera U.S. Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesFronthera U.S. Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A